AVECRIS Pte. Ltd.

AVECRIS is developing an advanced non-viral gene delivery platform that will enable next generation gene therapy and genetic vaccination. AVECRIS’s vectors are redosable and non-immunogenic, offering stable and long-lasting gene expression.